2020 · 92 citations · 5 references
Point-of-care TestingEngineeringViral DiagnosticsDiagnosisNucleic Acid Amplification TestRapid DetectionCovid-19Diagnostic TestRapid Diagnostic TestClinical EpidemiologySimulated Patient SamplesMolecular DiagnosticsLong CovidNovel CoronavirusVirologyCovid-19 DetectionEpidemiologyBiomolecular EngineeringMolecular Diagnostic TechniquesNucleic Acid AmplificationMedicine
Abstract Novel Corona virus (COVID-19 or 2019-nCoV) is an emerging global health concern that requires a rapid diagnostic test. Quantitative reverse transcription PCR (qRT-PCR) is currently the standard for COVID-19 detection; however, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) may allow for faster and cheaper field based testing at point-of-risk. The objective of this study was to develop a rapid screening diagnostic test that could be completed in under 30 minutes. Simulated patient samples were generated by spiking serum, urine, saliva, oropharyngeal swabs, and nasopharyngeal swabs with a portion of the COVID-19 nucleic sequence. The samples were tested using RT-LAMP as well as by conventional qRT-PCR. Specificity of the RT-LAMP was evaluated by also testing against other related coronaviruses. RT-LAMP specifically detected COVID-19 in simulated patient samples. This test was performed in under 30 minutes. This approach could be used for monitoring of exposed individuals or potentially aid with screening efforts in the field and potential ports of entry.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.3K citations · Full text